These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37245330)

  • 21. Determination of elemental impurities in lomefloxacin hydrochloride ear drops by inductively coupled plasma-mass spectrometry using oxygen reaction mode and study of their catalytic effect on photodegradation reaction.
    Xu B; Gao J; Li P; Zeng H; Su W; Wang J
    Rapid Commun Mass Spectrom; 2023 Mar; 37(6):e9468. PubMed ID: 36597261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of the impurity in auramine O by high performance liquid chromatography-ion trap-time of flight mass spectrometry and preparation of the auramine O reference standard by preparative high performance liquid chromatography].
    Che F; Lu Y; Xi X; Lan T; Wei Y
    Se Pu; 2019 Mar; 37(3):299-304. PubMed ID: 30900859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of the impurities in
    Ma X; Jin L; Li Y; Zheng H; Wei Y
    Se Pu; 2018 Mar; 36(3):268-277. PubMed ID: 30136505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a new component and impurities in josamycin by trap-free two-dimensional liquid chromatography coupled to ion trap time-of-flight mass spectrometry.
    Liu G; Xu Y; Sang J; Zhu B; Wang J
    Rapid Commun Mass Spectrom; 2019 Jun; 33(12):1058-1066. PubMed ID: 30907019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a new HPLC-MS method for meglumine impurity profiling.
    Martano C; Ferretti F; Ghiani S; Buonsanti F; Bruno E; Lattuada L; Medana C
    J Pharm Biomed Anal; 2018 Feb; 149():517-524. PubMed ID: 29175747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of teicoplanin impurities by two-dimensional ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry].
    Shao W; Chen Y; Yuan H; Jin M; Zhou X; Qin Y; Yang H; He Y
    Se Pu; 2023 Feb; 41(2):195-204. PubMed ID: 36725716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation and characterization of allergic polymerized impurities in cephalosporins by 2D-HPSEC×LC-IT-TOF MS.
    Xu Y; Wang D; Tang L; Wang J
    J Pharm Biomed Anal; 2017 Oct; 145():742-750. PubMed ID: 28806571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using thermal forced degradation approach for impurity profiling of budesonide solution-formulated metered dose inhalation with implementation of LC-QTOFMS and HPLC-UV.
    Peng M; Song D; Ling X; Jiang W; Zhang Y; Yang Y; Le J
    J Pharm Biomed Anal; 2022 Jan; 208():114445. PubMed ID: 34763210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semi-preparative isolation and structural elucidation of an impurity in citalopram by LC/MS/MS.
    Raman B; Sharma BA; Ghugare PD; Karmuse PP; Kumar A
    J Pharm Biomed Anal; 2009 Oct; 50(3):377-83. PubMed ID: 19556091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Separation and identification of impurities from intermediates of istradefylline].
    Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
    Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of impurities in the repurposed COVID-19 drug hydroxychloroquine sulfate using ultra-high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry and liquid chromatography-solid-phase extraction-nuclear magnetic resonance.
    Xu D; Pan F; Ruan H; Sun N
    Rapid Commun Mass Spectrom; 2022 Oct; 36(20):e9358. PubMed ID: 35880971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of impurities in sodium cromoglycate drug substance and eye drops using LC-ESI-ion trap MS and LC-ESI-QTOF MS.
    Zhu P; Lu J; Wang Z; Su W; Chen Y; Schepdael AV; Adams E
    J Pharm Biomed Anal; 2017 Oct; 145():537-548. PubMed ID: 28756173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of the impurity profile and characteristic fragmentation of Δ
    Ren X; Zhou J; Hu F; Wang J
    Rapid Commun Mass Spectrom; 2020 Dec; 34(23):e8948. PubMed ID: 32957160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a method of analysis for profiling of the impurities in phenoxymethylpenicillin potassium based on the analytical quality by design concept combined with the degradation mechanism of penicillins.
    Du J; Chang Y; Zhang X; Hu C
    J Pharm Biomed Anal; 2020 Jul; 186():113309. PubMed ID: 32380353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation, structure elucidation, and high-performance liquid chromatography quantification of photolytic degradation impurities in acrivastine.
    Lv JJ; Yu J; Zeng XY; Zeng X; Li Y; He DX; Lin YM
    J Sep Sci; 2022 Sep; 45(18):3480-3490. PubMed ID: 35853230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.